The FDA has approved a new inhaled antibiotic to treat cystic fibrosis (CF) patients infected with Pseudomonas aeruginosa.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content